FAM200A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.018140E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.496200E-01
Normal-vs-Stage2
3.219100E-04
Normal-vs-Stage3
7.556000E-04
Normal-vs-Stage4
9.929600E-01
Stage1-vs-Stage2
1.297430E-01
Stage1-vs-Stage3
2.728000E-02
Stage1-vs-Stage4
7.556600E-01
Stage2-vs-Stage3
4.841500E-03
Stage2-vs-Stage4
4.046000E-01
Stage3-vs-Stage4
6.162300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.638620E-03
Normal-vs-AfricanAmerican
4.491200E-01
Normal-vs-Asian
9.700100E-03
Caucasian-vs-AfricanAmerican
9.176200E-01
Caucasian-vs-Asian
2.776800E-01
AfricanAmerican-vs-Asian
3.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.444590E-04
Normal-vs-Female
7.972400E-02
Male-vs-Female
2.013800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.654200E-01
Normal-vs-Age(41-60Yrs)
7.588400E-01
Normal-vs-Age(61-80Yrs)
4.03350000000025E-05
Normal-vs-Age(81-100Yrs)
4.550000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.381000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.849600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.553800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.754260E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.668310E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.770600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.502300E-02
Normal-vs-Daily Drinker
1.595260E-03
Normal-vs-Weekly Drinker
5.622100E-02
Normal-vs-Occasional Drinker
7.543200E-01
Normal-vs-Social Drinker
8.963800E-01
Non Drinker-vs-Daily Drinker
8.421600E-01
Non Drinker-vs-Weekly Drinker
9.890200E-01
Non Drinker-vs-Occasional Drinker
1.191380E-01
Non Drinker-vs-Social Drinker
1.096140E-02
Daily Drinker-vs-Weekly Drinker
8.806000E-01
Daily Drinker-vs-Occasional Drinker
1.478010E-01
Daily Drinker-vs-Social Drinker
2.948400E-02
Weekly Drinker-vs-Occasional Drinker
1.271790E-01
Weekly Drinker-vs-Social Drinker
1.928400E-02
Occasional Drinker-vs-Social Drinker
7.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.828000E-02
Normal-vs-Grade 2
4.158200E-03
Normal-vs-Grade 3
1.630620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.458780E-01
Grade 1-vs-Grade 3
7.884000E-01
Grade 1-vs-Grade 4
5.828000E-02
Grade 2-vs-Grade 3
1.134560E-01
Grade 2-vs-Grade 4
4.158200E-03
Grade 3-vs-Grade 4
1.630620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.44299999996311E-06
Normal-vs-NonDiabetic
7.462900E-03
Diabetic-vs-NonDiabetic
2.985700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.603300E-03
Normal-vs-NoPancreatitis
1.017010E-03
Pancreatitis-vs-NoPancreatitis
2.306000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.004200E-03
Normal-vs-N1
9.597100E-04
N0-vs-N1
9.958000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.626200E-01
Normal-vs-TP53-NonMutant
8.792200E-01
TP53-Mutant-vs-TP53-NonMutant
7.912600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
